Medical News

RSS

patients with KRAS wild-type MCRC can benefit from Cetuximab Or Bevacizumab With Combi Chemo Equivalent For patients with KRAS wild-type MCRC

For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.

30 Jun 2014

Single gene defines difference between aggressive and non-aggressive forms of thymoma

For a rare form of cancer called thymoma, researchers have discovered a single gene defining the difference between a fast-growing tumor requiring aggressive treatment and a slow-growing tumor that doesn't require extensive therapy.

30 Jun 2014

MedicAlert Foundation announces free medical IDs for individuals living with Malignant Hyperthermia

MedicAlert Foundation is pleased to announce that individuals living with Malignant Hyperthermia (MH) are now eligible to receive free medical IDs and live 24/7 emergency response services as the result of a grant obtained through the Sandi Ida Glickstein Fund at the Malignant Hyperthermia Association of the United States.

28 Jun 2014

Chesapeake Urology presents $114,248 to Urology Care Foundation for prostate cancer research

In ongoing support of prostate cancer research, Sanford Siegel, M.D., President and CEO of Chesapeake Urology Associates, presented the Urology Care Foundation with a check for $114,248 in support of its prostate cancer research efforts.

28 Jun 2014

Dr. Cayce Jehaimi receives Patients' Choice Award

Among the select few physicians honored with the prestigious Patients' Choice Award this year is Dr. Cayce Jehaimi.

28 Jun 2014

Congressman Chaka Fattah to be featured speaker at Neuroscience Policy Symposia Series

Congressman Chaka Fattah (D-PA), will be the featured speaker at a neurotechnology seminar this Monday, June 30, as part of the Potomac Institute's 2014 Neuroscience Policy Symposia Series.

28 Jun 2014

CTPF receives more than $585M from Chicago Board of Education

The Chicago Teachers' Pension Fund (CTPF) received more than $585 million earlier today, completing the $612.5 million required contribution from the Chicago Board of Education (BOE) for the 2014 fiscal year.

28 Jun 2014

President and CEO of Donor Alliance receives AOPO Cryolife Achievement Award

Sue Dunn, president and CEO of Donor Alliance, is the 2014 recipient of the Association of Organ Procurement Organizations (AOPO) Cryolife Achievement Award, a national distinction.

28 Jun 2014

Proper planning and training for MSLs on iPad usage is essential for success

The iPad is quickly supplanting laptops as the principal tool for enhancing Medical Science Liaisons' (MSLs) interactions with thought leaders.

28 Jun 2014

Study identifies effective market research approaches to understand payer needs, decision-making

The Affordable Care Act has been the catalyst for dramatic change in US healthcare. The power structures that influence this $2.8 trillion economic sector are shifting, but one thing is crystal clear: A large percentage of the pharmaceutical sector's top-line revenues flow from payers.

28 Jun 2014

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today detailed findings from its global Phase III RECOURSE trial of TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug.

28 Jun 2014

Viewpoints: Abortion rights buffer; coming 'freakout' on health law; repercussions of malaria prevention

A Unanimous Supreme Court: Abortion Rights Lose A Buffer Yet on Thursday the Supreme Court, in McCullen v. Coakley, struck down that law for violating the First Amendment.

28 Jun 2014

BRI to present clinical-stage product data at International Symposium on Pediatric Neuro-Oncology

The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal®) and Antineoplaston AS2-1 injections (Astugenal®), at the 16th International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014.

28 Jun 2014

ARC Healthcare to continue payment of monthly distributions at $0.68 per share

American Realty Capital Healthcare Trust, Inc. ("ARC Healthcare") announced today that, pursuant to the prior authorization of its board of directors, ARC Healthcare intends to continue payment of monthly distributions at an annualized rate of $0.68 per share.

28 Jun 2014

American Academy of Ophthalmology does not recommend marijuana for glaucoma treatment

The American Academy of Ophthalmology – the world's largest association of eye physicians and surgeons – is reminding the public that it does not recommend marijuana or other cannabis products for the treatment of glaucoma.

28 Jun 2014

New concussion therapy program for NFL members

Upledger Institute Clinic in conjunction with the Ricky Williams Foundation announced today the launch of their concussion therapy pilot program aimed at treating current and former members of the NFL.

28 Jun 2014

Men advised to take proactive approach to prevent hernia

As the preeminent hernia specialist in the Western United States, Dr. Shirin Towfigh has diagnosed and treated a number of patients through incisional hernia surgery and other cutting-edge techniques.

28 Jun 2014

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.

28 Jun 2014

GNS automated data analytics can predict future risk of metabolic syndrome in patients

Research published today in The American Journal of Managed Care demonstrates that analysis of patient records using state-of-the-art data analytics can predict future risk of metabolic syndrome.

28 Jun 2014

Valent Biosciences opens new biorational manufacturing facility in Iowa

Valent BioSciences Corporation (VBC) today marked the official opening of its new $146 million biorational manufacturing facility in Osage, IA in a ceremony that included more than 130 international dignitaries, state and local VIPs, and media personnel.

28 Jun 2014

Medical News

patients with KRAS wild-type MCRC can benefit from Cetuximab Or Bevacizumab With Combi Chemo Equivalent For patients with KRAS wild-type MCRC

Single gene defines difference between aggressive and non-aggressive forms of thymoma

MedicAlert Foundation announces free medical IDs for individuals living with Malignant Hyperthermia

Chesapeake Urology presents $114,248 to Urology Care Foundation for prostate cancer research

Dr. Cayce Jehaimi receives Patients' Choice Award

Congressman Chaka Fattah to be featured speaker at Neuroscience Policy Symposia Series

CTPF receives more than $585M from Chicago Board of Education

President and CEO of Donor Alliance receives AOPO Cryolife Achievement Award

Proper planning and training for MSLs on iPad usage is essential for success

Study identifies effective market research approaches to understand payer needs, decision-making

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Viewpoints: Abortion rights buffer; coming 'freakout' on health law; repercussions of malaria prevention

BRI to present clinical-stage product data at International Symposium on Pediatric Neuro-Oncology

ARC Healthcare to continue payment of monthly distributions at $0.68 per share

American Academy of Ophthalmology does not recommend marijuana for glaucoma treatment

New concussion therapy program for NFL members

Men advised to take proactive approach to prevent hernia

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

GNS automated data analytics can predict future risk of metabolic syndrome in patients

Valent Biosciences opens new biorational manufacturing facility in Iowa

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News